Lambert Eaton myasthenic syndrome antibody testing and treatment recommendations added to NCCN Clinical Practice Guidelines for small cell lung cancer – Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc. announced the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Small Cell Lung Cancer (SCLC) now include new additions involving Lambert Eaton… read more.